TD Cowen Maintains Hold on DarioHealth, Lowers Price Target to $8

Benzinga Newsdesk www.benzinga.com Negative 85.5%

Neg 85.5% Neu 0% Pos 0%

TD Cowen analyst Charles Rhyee maintains DarioHealth (NASDAQ:DRIO) with a Hold and lowers the price target from $11 to $8.